FCDAX
Price
$48.78
Change
+$0.81 (+1.69%)
Updated
Jul 30 closing price
Net Assets
7.54B
VSCPX
Price
$409.05
Change
+$3.69 (+0.91%)
Updated
Jul 30 closing price
Net Assets
188.57B
Interact to see
Advertisement

FCDAX vs VSCPX

FCDAX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
FCDAX vs. VSCPX commentary
Jul 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCDAX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 189B vs. FCDAX (7.54B). VSCPX pays higher dividends than FCDAX: VSCPX (1.20) vs FCDAX (0.04). FCDAX was incepted earlier than VSCPX: FCDAX (19 years) vs VSCPX (16 years). FCDAX (1.13) is less costly to investors than VSCPX (0.02). FCDAX is a more actively managed with annual turnover of: 46.00 vs. VSCPX (17.00). FCDAX has a lower initial minimum investment than VSCPX: FCDAX (0) vs VSCPX (100000000). FCDAX annual gain was more profitable for investors over the last year : 30.77 vs. VSCPX (20.55). FCDAX return over 5 years is better than : 41.46 vs. VSCPX (34.25).
FCDAXVSCPXFCDAX / VSCPX
Total Expense Ratio1.130.025,650%
Annual Report Gross Expense Ratio1.130.025,650%
Fund Existence19 years16 years-
Gain YTD17.63113.833127%
Front Load6%N/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.54B189B4%
Annual Yield % from dividends0.041.203%
Returns for 1 year30.7720.55150%
Returns for 3 years55.7541.96133%
Returns for 5 years41.4634.25121%
Returns for 10 years101.20151.1867%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPSX37.52N/A
N/A
ProFunds Pharmaceuticals UltraSector Svc
SSTFX9.53N/A
N/A
Virtus KAR Capital Growth C
IVPOX22.01N/A
N/A
Voya SmallCap Opportunities Port S
ETIHX55.22N/A
N/A
Eventide Healthcare & Life Sciences I
PMYAX51.72N/A
N/A
Putnam Core Equity Fund A